Mindfulness Based Cognitive Therapy and Antidepressant Medication in Recurrent Depression

• Status: Completed
• Trial end date: 2013-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the (cost)effectiveness of mindfulness based cognitive therapy (MBCT) compared to that of antidepressant medication, and its combination with regard to the prevention of relapse or recurrence in patients with recurrent depression.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Radboud University
• Collaborator: ZonMw: The Netherlands Organisation for Health Research and Development
• Treatments: Antidepressive Agents

Criteria

Inclusion Criteria:

• Recurrent Major Depressive Episode (at least 3 previous episodes)

• Treatment with therapeutic dose of antidepressant medication during past six months

• Currently in full or partial remission

Exclusion Criteria:

• Bipolar disorder (current and previous (hypo)manic episodes)

• Psychotic disorder (current and previous)

• Neurological or somatic illness affecting depression or outcome measures

• Current alcohol or drugs dependency

• Use of high dosage benzodiazepines (> 2 mg Lorazepam equivalents daily)

• Recent Electro Convulsive Therapy (< 3 months ago)